Brain-Derived Neurotrophic Factor Administration Mediated Oligodendrocyte Differentiation and Myelin Formation in Subcortical Ischemic Stroke
Author(s) -
Jaime RamosCejudo,
María GutiérrezFernández,
Laura OteroOrtega,
Berta RodríguezFrutos,
Blanca Fuentes,
María Teresa VallejoCremades,
Teresa Navarro Hernanz,
Sebastián Cerdán,
Exuperio Díez–Tejedor
Publication year - 2014
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.114.006692
Subject(s) - remyelination , oligodendrocyte , medicine , neurotrophic factors , white matter , myelin basic protein , brain derived neurotrophic factor , endocrinology , olig2 , myelin , vascular endothelial growth factor , neuroscience , receptor , central nervous system , magnetic resonance imaging , biology , radiology , vegf receptors
Translational research is beginning to reveal the importance of trophic factors as a therapy for cellular brain repair. The purpose of this study was to analyze whether brain-derived neurotrophic factor (BDNF) administration could mediate oligodendrogenesis and remyelination after white matter injury in subcortical stroke.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom